Diagnosed prevalence of Alzheimer's disease and related dementias in Medicare Advantage plans

Diagnosed prevalence of Alzheimer's disease and related dementias in Medicare Advantage plans

Abstract Introduction One‐third of Medicare beneficiaries are enrolled in Medicare Advantage (MA). Yet, little is known about MA beneficiaries diagnosed with Alzheimer's disease (AD) and AD‐related dementias (AD/ADRD). Methods We calculated the prevalence of AD/ADRD diagnoses in 2014 and 2016 i...

Full description

Bibliographic Details
Main Authors: Eric Jutkowitz, Julie P.W. Bynum, Susan L. Mitchell, Noelle M. Cocoros, Oren Shapira, Kevin Haynes, Vinit P. Nair, Cheryl N. McMahill‐Walraven, Richard Platt, Ellen P. McCarthy
Format: Article
Language:English
Published: Wiley 2020-01-01
Series:Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring
Subjects:
Medicare
Medicare Advantage
dementia, Alzheimer's disease
mild cognitive impairment
Online Access:https://doi.org/10.1002/dad2.12048

Internet

https://doi.org/10.1002/dad2.12048

Similar Items